Yesterday, the Nemura Medical Inc (NASDAQ:NMRD) stock emerged as one of the major gainers yesterday. The medical technology company saw its stock soar by as much as 135% and this morning, it is on the move again in the premarket trading period, having gone up by another 23%.
Nemura is a medical technology firm and yesterday it announced that it received a purchase order for 200,000 units of SugarBEAT sensors and 5000 units of SugarBEAT transmitters.
The purchase order had been placed by DB Ethitronix Ltd, the company’s licensee in the United Kingdom. In addition to that, it is also necessary to point out that there has also been an agreement regarding a monthly rolling order over the next 24 months for 2.1 million sensors and 15,000 transmitters. Moreover, the quantum of the orders could rise if there is an enthusiastic response from the customers. It is a significant development for Nemura and it remains to be seen if the stock can continue to record gains over the coming days.
NMRD stock is up 23.605 at $13.67 in the pre-market session.
Writing for business and finance publishers has become his passion over the last decades after he completed a master’s degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.